MR perfusion imaging of the kidney pre- and post-dipyridamole stress.
Animal studies have demonstrated that renal MR contrast enhancement depends on the timing of image acquisition. Limited human studies have demonstrated effects of dipyridamole (DP) on total renal perfusion. This study assessed the effect of DP on total and regional renal perfusion using gated perfusion MRI for patients undergoing DP stress. Five subjects with no evidence of renal ischemia were examined at rest and after DP stress. Rest MRI images in the left kidney were acquired using electrocardiogram (ECG)-gated MR: turbo fast low-angle shot (FLASH); echo time (TE) = 12, repetition time (TR) = 6, flip angle = 12, inversion time (TI) = 100) 10 to 45 seconds after injection of gadopentetate dimeglumine. Stress was induced in the MRI scanner (DP, .56 mg/kg over 4 minutes) followed by stress MRI after a second bolus of gadopentetate dimeglumine in the same position and identical time intervals. MR signal in the whole left kidney and renal medulla and cortex pre- and post-DP demonstrated a 70% depression of total renal perfusion with relative preservation of cortical perfusion at the expense of medullary perfusion. Post-DP MR images demonstrated a decrease in cortical perfusion with an additional 29% depression of medullary perfusion (P < .001) with respect to cortical perfusion. Turbo FLASH MRI can provide adequate time and spatial resolution to demonstrate changes in renal perfusion. Depression of renal medullary perfusion after DP appears to be caused by the intrarenal effect of DP and may have clinical impact.
Tello
R
R
Harvard Medical School, Department of Diagnostic Radiology, Brigham and Women's Hospital, Boston, MA 02215, USA.
Hartnell
G G
GG
Hill
T
T
Volpe
J
J
Finn
J P
JP
Cohen
M
M
D000368:Aged; D001783:Blood Flow Velocity / Q000502:physiology; D003287:Contrast Media; D004176:Dipyridamole; D004338:Drug Combinations; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D007089:Image Enhancement / Q000295:instrumentation*; D007091:Image Processing, Computer-Assisted / Q000295:instrumentation*; D007511:Ischemia / Q000175:diagnosis* / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply*; D007672:Kidney Cortex / Q000098:blood supply; D007679:Kidney Medulla / Q000098:blood supply; D008279:Magnetic Resonance Imaging / Q000295:instrumentation*; D008297:Male; D008536:Meglumine; D008875:Middle Aged; D009942:Organometallic Compounds; D004369:Pentetic Acid / Q000031:analogs & derivatives; D012039:Regional Blood Flow; D014665:Vasodilator Agents
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D014665:Vasodilator Agents; D004176:Dipyridamole; D008536:Meglumine; D004369:Pentetic Acid; D019786:Gadolinium DTPA